Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
RNA, 5S ribosomal pseudogene 293 (RNA5SP293) is a human genomic locus transcribed as a non-coding RNA, annotated as a pseudogene related to the 5S ribosomal RNA gene family[2][5]. As a pseudogene, RNA5SP293 contains sequence similarity to functional 5S rRNA genes but is believed to lack protein-coding capability and ribosomal function due to disabling mutations or truncations[4][5]. It is not a protein, enzyme, receptor, or therapeutic target. Pseudogenes like RNA5SP293 do not serve canonical cellular functions attributed to their archetype rRNA genes (such as participating in ribosome structure or activity)[4]. However, emerging research demonstrates that, while individual pseudogenes like RNA5SP293 do not have a direct biochemical or signaling role, patterns of pseudogene expression—including members of the 5S rRNA pseudogene family—may correlate with molecular subtypes of cancer, prognosis, and possibly other disease-relevant states[6]. Thus, their expression can be useful in systems-level molecular profiling and may serve as potential biomarkers, but RNA5SP293 itself is not a recognized molecular target for therapeutic action, nor does it play a direct role in normal biology or disease mechanism[6]. RNA5SP293’s only established role is as a molecular “footprint”—a proxy for broader transcriptional regulatory phenomena involving pseudogenes and non-coding RNAs in complex conditions such as cancer.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on RNA, 5S ribosomal pseudogene 293 (RNA5SP293).